Boston Scientific Corporation
Boston Scientific Corporation (BSX) Stock Overview
Explore Boston Scientific Corporation’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
152.2B
P/E Ratio
60.82
EPS (TTM)
$1.68
ROE
0.12%
BSX Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Boston Scientific Corporation (BSX) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 43.44, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $126.90.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 60.82 and a market capitalization of 152.2B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.